Dr. Lourdes M Del Campo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: # 261 Urb. Ciudad Jardin, St Bauhinia, Toa Alta, PR 00953 Phone: 787-279-5111 |
Mrs. Ana M Rodriguez Santiago, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Rio Del Plata Mall, Oficina 12 B, Toa Alta, PR 00953 Phone: 787-870-4069 Fax: 787-870-4725 |
Dr. Wanda Robles Quiles, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Brisas De Montecasino #544 Calle Taino, Toa Alta, PR 00953 Phone: 787-312-4645 |
Dr. Carmen G Golderos, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12-b Rio Del Plata Mall, Urb. Jardines De Toa Alta, Toa Alta, PR 00953 Phone: 787-870-4069 Fax: 787-870-4725 |
Dr. Carmen Lopez, MD, MPH Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 364 Calle Mirto, Monte Casino, Toa Alta, PR 00953 Phone: 787-948-3069 |
Dr. Juan Carlos Del Rio Roure, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 162 Begonia Street, Ciudad Jardin 2, Toa Alta, PR 00953 Phone: 787-730-1166 |
News Archive
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, and The Association of Women's Health, Obstetric and Neonatal Nurses have announced that Elsevier will publish AWHONN's official publications, Journal of Obstetric, Gynecologic & Neonatal Nursing and Nursing for Women's Health, beginning with the 2016 volumes.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that it retained $30,064,684 from a payment from Covidien, following the Ninth Circuit Court of Appeals' October 2009 affirmance of a Federal District Court decision that Tyco Healthcare, now Covidien, violated the antitrust laws through anticompetitive business practices related to the sale of its pulse oximetry products.
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its operating results for the third quarter of 2013.
Frost & Sullivan is pleased to announce the award of its prestigious 2010 European Influenza Vaccines Technology Innovation Award to BiondVax Pharmaceuticals for their breakthrough work on a universal influenza vaccine. This vaccine, the Multimeric-001, is designed to provide multi-season and multi-strain protection against most influenza virus strains, including both seasonal and pandemic strains, and has the potential to eliminate the need for annual flu vaccination. BiondVax is entering Phase II clinical trials for the development of the Multimeric-001 universal influenza vaccine.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 8 days ago